DSM Managing Board re-appointments
(Thomson Reuters ONE) -
Royal DSM, the global Life Sciences and Materials Sciences company, today
announces the proposed re-appointment of Stephan B. Tanda as member of the DSM
Managing Board at the upcoming Annual General Meeting of Shareholders (AGM) on
30 April 2015. DSM also announces the departure of DSM Managing Board member
Stefan Doboczky per 1 June 2015.
The transformation of the DSM pharmaceutical activities was completed in 2014,
and DSM now holds participations in two joint ventures. As a result, it has been
agreed between DSM and Stefan Doboczky that his term as a Managing Board member
will not be renewed at the upcoming AGM. Stefan will leave DSM per 1 June and
has accepted employment outside of DSM.
Stefan Doboczky has worked in DSM's Pharma businesses for 17 years and has, as a
Managing Board member, successfully led the design and execution of the Pharma
strategy, resulting in the creation of DSM Sinochem Pharmaceuticals (DSP,
Antibiotics JV with Sinochem) and DPx (Pharma JV with JLL/Patheon).
The responsibilities of Stefan Doboczky will be redistributed among the current
Managing Board members.
Feike Sijbesma, CEO and Chairman of the DSM Managing Board, commented: "During
the years that Stefan worked for DSM in Pharma and as Regional President in
Asia, he spearheaded many strategic growth initiatives that helped transform our
business. DSM is very grateful for the contribution he has made over many years
and, also on behalf of my colleagues, I wish him every success in the next step
in his career."
DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and
materials. By connecting its unique competences in Life Sciences and Materials
Sciences DSM is driving economic prosperity, environmental progress and social
advances to create sustainable value for all stakeholders simultaneously. DSM
delivers innovative solutions that nourish, protect and improve performance in
global markets such as food and dietary supplements, personal care, feed,
medical devices, automotive, paints, electrical and electronics, life
protection, alternative energy and bio-based materials. DSM and its associated
companies deliver annual net sales of about ?10 billion with approximately
25,000 employees. The company is listed on Euronext Amsterdam. More information
can be found at www.dsm.com.
Or find us on:
For more information:
DSM Corporate Communications DSM Investor Relations
Herman Betten Dave Huizing
tel. +31 (0) 45 5782017 tel. +31 (0) 45 5782864
e-mail media.contacts(at)dsm.com e-mail investor.relations(at)dsm.com
Press release-pdf:
http://hugin.info/130663/R/1904285/677407.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: DSM N.V. via GlobeNewswire
[HUG#1904285]
Unternehmensinformation / Kurzprofil:
Datum: 18.03.2015 - 08:15 Uhr
Sprache: Deutsch
News-ID 379322
Anzahl Zeichen: 3592
contact information:
Town:
Heerlen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 158 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DSM Managing Board re-appointments"
steht unter der journalistisch-redaktionellen Verantwortung von
DSM N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
